Purple Biotech Ltd. (NASDAQ: PPBT) Stock Information | RedChip

Purple Biotech Ltd. (NASDAQ: PPBT) Listen to this Section


$0.37
+0.0082 ( +2.27% ) 97.8K

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Market Data


Open


$0.37

Previous close


$0.36

Volume


97.8K

Market cap


$11.50M

Day range


$0.36 - $0.38

52 week range


$0.30 - $1.80

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
20-f Annual reports 110 Mar 05, 2024
6-k Quarterly Reports 2 Feb 27, 2024
6-k Quarterly Reports 2 Feb 13, 2024
6-k Quarterly Reports 2 Feb 01, 2024
6-k Quarterly Reports 1 Jan 26, 2024
6-k Quarterly Reports 2 Dec 20, 2023
6-k Quarterly Reports 2 Dec 14, 2023
6-k Quarterly Reports 44 Nov 21, 2023
6-k Quarterly Reports 2 Nov 21, 2023
6-k Quarterly Reports 2 Nov 02, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.